{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:47:08Z","timestamp":1790333228943,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["MP\/19200"],"award-info":[{"award-number":["MP\/19200"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011719","name":"Bone Cancer Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4468-5","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T11:57:30Z","timestamp":1525780650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis"],"prefix":"10.1186","volume":"18","author":[{"given":"T.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kastrenopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Larrouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Athanasou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9575-6067","authenticated-orcid":false,"given":"H. J.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"4468_CR1","doi-asserted-by":"publisher","unstructured":"Brown HK, Schiavone K, Gouin F, Heymann MF, Heymann D. Biology of bone sarcomas and new therapeutic developments. Calcif Tissue Int. 2017; https:\/\/doi.org\/10.1007\/s00223-017-0372-2 .","DOI":"10.1007\/s00223-017-0372-2"},{"key":"4468_CR2","first-page":"127","volume":"37","author":"QC Yang","year":"2007","unstructured":"Yang QC, Zeng BF, Dong Y, Shi ZM, Jiang ZM, Huang J. Overexpression of hypoxia-inducible Factor-1{alpha} in human osteosarcoma: correlation with Clinicopathological parameters and survival outcome. Jap. J Clin Oncol. 2007;37:127\u201334.","journal-title":"J Clin Oncol"},{"key":"4468_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1007\/s11999-008-0328-y","volume":"466","author":"H Mizobuchi","year":"2008","unstructured":"Mizobuchi H, Garcia-Castellano JM, Philip S, Healey JH, Gorlick R. Hypoxia markers in human osteosarcoma: an exploratory study. Clin Orthop Rel Res. 2008;466:2052\u20139.","journal-title":"Clin Orthop Rel Res"},{"key":"4468_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13046-015-0135-8","volume":"34","author":"T Hu","year":"2015","unstructured":"Hu T, He N, Yang Y, Yin C, Sang N, Yang Q. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. J Exp Clin Cancer Res. 2015;34:22.","journal-title":"J Exp Clin Cancer Res"},{"key":"4468_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1186\/s40064-016-3064-x","volume":"5","author":"Y Li","year":"2016","unstructured":"Li Y, Zhang W, Li S, Tu C. Prognosis value of hypoxia-inducible factor-1alpha expression in patients with bone and soft tissue sarcoma: a meta-analysis. SpringerPlus. 2016;5:1370.","journal-title":"SpringerPlus"},{"key":"4468_CR6","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.5301\/jbm.5000216","volume":"31","author":"Y Ouyang","year":"2016","unstructured":"Ouyang Y, Li H, Bu J, Li X, Chen Z, Xiao T. Hypoxia-inducible factor-1 expression predicts osteosarcoma patients' survival: a meta-analysis. Int J Biol Markers. 2016;31:e229\u201334.","journal-title":"Int J Biol Markers"},{"key":"4468_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3892\/ol.2012.604","volume":"3","author":"Y Chen","year":"2012","unstructured":"Chen Y, Yang Y, Yuan Z, Wang C, Shi Y. Predicting chemosensitivity in osteosarcoma prior to chemotherapy: an investigational study of biomarkers with immunohistochemistry. Oncol Lett. 2012;3:1011\u20136.","journal-title":"Oncol Lett"},{"key":"4468_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.prp.2016.06.013","volume":"212","author":"W Li","year":"2016","unstructured":"Li W, He X, Xue R, Zhang Y, Zhang X, Lu J, et al. Combined over-expression of the hypoxia-inducible factor 2alpha gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma. Pathol Res Practice. 2016;212:861\u20136.","journal-title":"Pathol Res Practice"},{"key":"4468_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2407-10-372","volume":"10","author":"HJ Knowles","year":"2010","unstructured":"Knowles HJ, Schaefer KL, Dirksen U, Athanasou NA. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of hypoxia-inducible factor. BMC Cancer. 2010;10:10.","journal-title":"BMC Cancer"},{"key":"4468_CR10","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3892\/mmr.2017.6243","volume":"15","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wang X, Su X, Liu T. HIF-2alpha affects proliferation and apoptosis of MG-63 osteosarcoma cells through MAPK signaling. Mol Med Rep. 2017;15:2174\u20138.","journal-title":"Mol Med Rep"},{"key":"4468_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3727\/096504016X14743337535446","volume":"25","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Yang C, Wang K, Liu X, Liu Q. MicroRNA-33b inhibits the proliferation and migration of osteosarcoma cells via targeting hypoxia-inducible factor-1alpha. Oncol Res. 2017;25:397\u2013405.","journal-title":"Oncol Res"},{"key":"4468_CR12","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.3892\/mmr.2015.3729","volume":"12","author":"J Li","year":"2015","unstructured":"Li J, Zhao K, Wang F, Cai J, Li Z, Zou L. X609, a novel manassantin a derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo. Mol Med Rep. 2015;12:3115\u201320.","journal-title":"Mol Med Rep"},{"key":"4468_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ijc.25024","volume":"127","author":"Y Shapovalov","year":"2010","unstructured":"Shapovalov Y, Benavidez D, Zuch D, Eliseev RA. Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma. Int J Cancer. 2010;127:67\u201376.","journal-title":"Int J Cancer"},{"key":"4468_CR14","doi-asserted-by":"publisher","unstructured":"Keremu A, Aini A, Maimaitirexiati Y, Liang Z, Aila P, Xierela P, et al. Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1alpha. Biosci Rep. 2017; https:\/\/doi.org\/10.1042\/BSR20170080 .","DOI":"10.1042\/BSR20170080"},{"key":"4468_CR15","doi-asserted-by":"publisher","first-page":"e0125125","DOI":"10.1371\/journal.pone.0125125","volume":"10","author":"H Choi","year":"2015","unstructured":"Choi H, Gillespie DL, Berg S, Rice C, Couldwell S, Gu J, et al. Intermittent induction of HIF-1alpha produces lasting effects on malignant progression independent of its continued expression. PLoS One. 2015;10:e0125125.","journal-title":"PLoS One"},{"key":"4468_CR16","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1096\/fj.10-162230","volume":"24","author":"HJ Knowles","year":"2010","unstructured":"Knowles HJ, Cleton-Jansen AM, Korsching E, Athanasou NA. Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB J. 2010;24:4648\u201359.","journal-title":"FASEB J"},{"issue":"3","key":"4468_CR17","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/hep.24479","volume":"54","author":"H Li","year":"2011","unstructured":"Li H, Ge C, Zhao F, Yan M, Hu C, Jia D, Tian H, Zhu M, Chen T, Jiang G, et al. Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1\/integrin beta1 signaling in human hepatocellular carcinoma. Hepatology. 2011;54(3):910\u20139.","journal-title":"Hepatology"},{"key":"4468_CR18","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/onc.2011.365","volume":"31","author":"H Zhang","year":"2012","unstructured":"Zhang H, Wong CC, Wei H, Gilkes DM, Korangath P, Chaturvedi P, et al. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene. 2012;31:1757\u201370.","journal-title":"Oncogene"},{"key":"4468_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1042\/BST0331059","volume":"33","author":"S Kersten","year":"2005","unstructured":"Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Transact. 2005;33:1059\u201362.","journal-title":"Biochem Soc Transact"},{"key":"4468_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tem.2013.12.005","volume":"2","author":"W Dijk","year":"2014","unstructured":"Dijk W, Kersten S. Regulation of lipoprotein lipase by Angptl4. Trends Endocrinol Metab. 2014;2:146\u201355.","journal-title":"Trends Endocrinol Metab"},{"key":"4468_CR21","doi-asserted-by":"publisher","first-page":"34411","DOI":"10.1074\/jbc.M403058200","volume":"279","author":"S Mandard","year":"2004","unstructured":"Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF\/PGAR\/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem. 2004;279:34411\u201320.","journal-title":"J Biol Chem"},{"key":"4468_CR22","doi-asserted-by":"publisher","first-page":"28488","DOI":"10.1074\/jbc.M004029200","volume":"275","author":"S Kersten","year":"2000","unstructured":"Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem. 2000;275:28488\u201393.","journal-title":"J Biol Chem"},{"key":"4468_CR23","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1128\/MCB.20.14.5343-5349.2000","volume":"20","author":"JC Yoon","year":"2000","unstructured":"Yoon JC, Chickering TW, Rosen ED, Dussault B, Qin YB, Soukas A, et al. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol. 2000;20:5343\u20139.","journal-title":"Mol Cell Biol"},{"key":"4468_CR24","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1073\/pnas.0408452102","volume":"102","author":"A Xu","year":"2005","unstructured":"Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, et al. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A. 2005;102:6086\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4468_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4161\/adip.20787","volume":"1","author":"SK Koliwad","year":"2012","unstructured":"Koliwad SK, Gray NE, Wang JC. Angiopoietin-like 4 (Angptl4): a glucocorticoid-dependent gatekeeper of fatty acid flux during fasting. Adipocyte. 2012;1:182\u20137.","journal-title":"Adipocyte"},{"key":"4468_CR26","doi-asserted-by":"publisher","first-page":"15747","DOI":"10.1074\/jbc.M110.217638","volume":"286","author":"X Lei","year":"2011","unstructured":"Lei X, Shi F, Basu D, Huq A, Routhier S, Day R, Jin W. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J Biol Chem. 2011;286:15747\u201356.","journal-title":"J Biol Chem"},{"key":"4468_CR27","doi-asserted-by":"publisher","first-page":"25593","DOI":"10.1074\/jbc.M109.025452","volume":"284","author":"SK Koliwad","year":"2009","unstructured":"Koliwad SK, Kuo T, Shipp LE, Gray NE, Backhed F, So AY, et al. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J Biol Chem. 2009;284:25593\u2013601.","journal-title":"J Biol Chem"},{"key":"4468_CR28","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S0002-9440(10)64285-X","volume":"162","author":"S Le Jan","year":"2003","unstructured":"Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, Favier J, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol. 2003;162:1521\u20138.","journal-title":"Am J Pathol"},{"key":"4468_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ccr.2011.01.018","volume":"19","author":"P Zhu","year":"2011","unstructured":"Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC, Pal M, et al. Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(\u2212):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell. 2011;19:401\u201315.","journal-title":"Cancer Cell"},{"key":"4468_CR30","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1182\/blood-2011-01-328716","volume":"118","author":"RL Huang","year":"2011","unstructured":"Huang RL, Teo Z, Chong HC, Zhu P, Tan MJ, Tan CK, et al. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. Blood. 2011;118:3990\u20134002.","journal-title":"Blood"},{"key":"4468_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/or_00000897","volume":"24","author":"T Nakayama","year":"2010","unstructured":"Nakayama T, Hirakawa H, Shibata K, Abe K, Nagayasu T, Taguchi T. Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion. Oncol Rep. 2010;24:599\u2013606.","journal-title":"Oncol Rep"},{"key":"4468_CR32","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3892\/or.2011.1176","volume":"25","author":"T Nakayama","year":"2011","unstructured":"Nakayama T, Hirakawa H, Shibata K, Nazneen A, Abe K, Nagayasu T, Taguchi T. Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis. Oncol Rep. 2011;25:929\u201335.","journal-title":"Oncol Rep"},{"key":"4468_CR33","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1136\/jcp.2010.078600","volume":"63","author":"K Shibata","year":"2010","unstructured":"Shibata K, Nakayama T, Hirakawa H, Hidaka S, Nagayasu T. Clinicopathological significance of angiopoietin-like protein 4 expression in oesophageal squamous cell carcinoma. J Clin Pathol. 2010;63:1054\u20138.","journal-title":"J Clin Pathol"},{"key":"4468_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/13547500903261362","volume":"15","author":"Z Wang","year":"2010","unstructured":"Wang Z, Han B, Zhang Z, Pan J, Xia H. Expression of angiopoietin-like 4 and tenascin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma. Biomarkers. 2010;15:39\u201346.","journal-title":"Biomarkers"},{"key":"4468_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1741-7015-7-9","volume":"7","author":"ZY Hu","year":"2009","unstructured":"Hu ZY, Fan C, Livasy C, He XP, Oh DS, Ewend MG, et al. A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med. 2009;7:14.","journal-title":"BMC Med"},{"key":"4468_CR36","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1158\/0008-5472.CAN-11-1262","volume":"71","author":"SH Kim","year":"2011","unstructured":"Kim SH, Park YY, Kim SW, Lee JS, Wang D, DuBois RN. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res. 2011;71:7010\u201320.","journal-title":"Cancer Res"},{"key":"4468_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2008.03.010","volume":"267","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Cao L, Li J, Liang X, Liu Y, Liu H, et al. Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells. Cancer Lett. 2008;267:106\u201315.","journal-title":"Cancer Lett"},{"key":"4468_CR38","doi-asserted-by":"publisher","first-page":"9236","DOI":"10.1158\/0008-5472.CAN-09-2067","volume":"69","author":"LF Tian","year":"2009","unstructured":"Tian LF, Zhou J, Casimiro MC, Liang B, Ojeifo JO, Wang M, et al. Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis. Cancer Res. 2009;69:9236\u201344.","journal-title":"Cancer Res"},{"key":"4468_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","volume":"133","author":"D Padua","year":"2008","unstructured":"Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massague J. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 2008;133:66\u201377.","journal-title":"Cell"},{"key":"4468_CR40","doi-asserted-by":"publisher","first-page":"e109524","DOI":"10.1371\/journal.pone.0109524","volume":"9","author":"C Swales","year":"2014","unstructured":"Swales C, Athanasou NA, Knowles HJ. Angiopoietin-like 4 is over-expressed in rheumatoid arthritis patients: association with pathological bone resorption. PLoS One. 2014;9:e109524.","journal-title":"PLoS One"},{"key":"4468_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1259\/0007-1285-59-703-667","volume":"59","author":"N Bathurst","year":"1986","unstructured":"Bathurst N, Sanerkin N, Watt I. Osteoclast-rich osteosarcoma. Brit. J Radiol. 1986;59:667\u201373.","journal-title":"J Radiol"},{"key":"4468_CR42","first-page":"1231","volume":"33","author":"S Avnet","year":"2008","unstructured":"Avnet S, Longhi A, Salerno M, Halleen JM, Perut F, Granchi D, et al. Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int J Oncol. 2008;33:1231\u20138.","journal-title":"Int J Oncol"},{"key":"4468_CR43","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-04-2463","volume":"65","author":"MB Mintz","year":"2005","unstructured":"Mintz MB, Sowers R, Brown KM, Hilmer SC, Mazza B, Huvos AG, et al. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Res. 2005;65:1748\u201354.","journal-title":"Cancer Res"},{"key":"4468_CR44","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1158\/1535-7163.MCT-08-0530","volume":"7","author":"T Akiyama","year":"2008","unstructured":"Akiyama T, Dass CR, Choong PF. Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway. Mol Cancer Ther. 2008;7:3461\u20139.","journal-title":"Mol Cancer Ther"},{"key":"4468_CR45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/jbmr.2182","volume":"29","author":"T Ohba","year":"2014","unstructured":"Ohba T, Cole HA, Cates JM, Slosky DA, Haro H, Ando T, et al. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. J Bone Mineral Res. 2014;29:1431\u201345.","journal-title":"J Bone Mineral Res"},{"key":"4468_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1302\/0301-620X.85B2.13257","volume":"85","author":"G Holzer","year":"2003","unstructured":"Holzer G, Krepler P, Koschat MA, Grampp S, Dominkus M, Kotz R. Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Joint Surg. 2003;85:231\u20137.","journal-title":"J Bone Joint Surg"},{"key":"4468_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/gcc.20717","volume":"49","author":"L Ottaviano","year":"2010","unstructured":"Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, et al. Molecular characterisation of commonly used cell lines for bone tumour research: a trans-European EuroBoNeT effort. Genes Chromosomes Cancer. 2010;49:40\u201351.","journal-title":"Genes Chromosomes Cancer"},{"key":"4468_CR48","first-page":"6130","volume":"63","author":"HM Sowter","year":"2003","unstructured":"Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res. 2003;63:6130\u20134.","journal-title":"Cancer Res"},{"key":"4468_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.semdp.2014.01.001","volume":"31","author":"JT Green","year":"2014","unstructured":"Green JT, Mills AM. Osteogenic tumors of bone. Semin Diag Pathol. 2014;31:21\u20139.","journal-title":"Semin Diag Pathol"},{"key":"4468_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1567-5769(01)00134-5","volume":"2","author":"N Miyamoto","year":"2002","unstructured":"Miyamoto N, Higuchi Y, Mori K, Ito M, Tsurudome M, Nishio M, et al. Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells. Int Immunopharmacol. 2002;2:25\u201338.","journal-title":"Int Immunopharmacol"},{"key":"4468_CR51","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1002\/jcb.23295","volume":"112","author":"J Costa-Rodrigues","year":"2011","unstructured":"Costa-Rodrigues J, Fernandes A, Fernandes MH. Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors. J Cell Biochem. 2011;112:3704\u201313.","journal-title":"J Cell Biochem"},{"key":"4468_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/path.2319","volume":"215","author":"HJ Knowles","year":"2008","unstructured":"Knowles HJ, Athanasou NA. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol. 2008;215:56\u201366.","journal-title":"J Pathol"},{"key":"4468_CR53","doi-asserted-by":"crossref","first-page":"54966","DOI":"10.18632\/oncotarget.18629","volume":"8","author":"B Li","year":"2017","unstructured":"Li B, Qian M, Cao H, Jia Q, Wu Z, Yang X, et al. TGF-beta2-induced ANGPTL4 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone. Oncotarget. 2017;8:54966\u201377.","journal-title":"Oncotarget"},{"key":"4468_CR54","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3892\/ol.2015.4011","volume":"11","author":"H Kubo","year":"2016","unstructured":"Kubo H, Kitajima Y, Kai K, Nakamura J, Miyake S, Yanagihara K, et al. Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer. Oncol Lett. 2016;11:1026\u201334.","journal-title":"Oncol Lett"},{"key":"4468_CR55","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.18632\/oncotarget.6868","volume":"7","author":"K Hu","year":"2016","unstructured":"Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, et al. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget. 2016;7:7816\u201328.","journal-title":"Oncotarget"},{"key":"4468_CR56","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.1038\/s41598-017-11769-x","volume":"7","author":"K Baba","year":"2017","unstructured":"Baba K, Kitajima Y, Miyake S, Nakamura J, Wakiyama K, Sato H, et al. Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines. Sci Rep. 2017;7:11127.","journal-title":"Sci Rep"},{"key":"4468_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2015.09.104","volume":"467","author":"X Li","year":"2015","unstructured":"Li X, Chen T, Shi Q, Li J, Cai S, Zhou P, Zhong Y, Yao L. Angiopoietin-like 4 enhances metastasis and inhibits apoptosis via inducing bone morphogenetic protein 7 in colorectal cancer cells. Biochem Biophys Res Commun. 2015;467:128\u201334.","journal-title":"Biochem Biophys Res Commun"},{"key":"4468_CR58","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3892\/or.2011.1598","volume":"27","author":"XF Huang","year":"2012","unstructured":"Huang XF, Han J, Hu XT, He C. Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines. Oncol Rep. 2012;27:1541\u20137.","journal-title":"Oncol Rep"},{"key":"4468_CR59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jop.12212","volume":"44","author":"J Tanaka","year":"2015","unstructured":"Tanaka J, Irie T, Yamamoto G, Yasuhara R, Isobe T, Hokazono C, et al. ANGPTL4 regulates the metastatic potential of oral squamous cell carcinoma. J Oral Path Med. 2015;44:126\u201333.","journal-title":"J Oral Path Med"},{"key":"4468_CR60","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1541-7786.MCR-11-0519","volume":"10","author":"MJ Tan","year":"2012","unstructured":"Tan MJ, Teo Z, Sng MK, Zhu P, Tan NS. Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer Res. 2012;10:677\u201388.","journal-title":"Mol Cancer Res"},{"key":"4468_CR61","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/BSR20110102","volume":"32","author":"P Zhu","year":"2012","unstructured":"Zhu P, Goh YY, Chin HF, Kersten S, Tan NS. Angiopoietin-like 4: a decade of research. Biosci Rep. 2012;32:211\u20139.","journal-title":"Biosci Rep"},{"key":"4468_CR62","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1210\/en.2013-1238","volume":"154","author":"JM Lin","year":"2013","unstructured":"Lin JM, Naot D, Watson M, Costa JL, Reid IR, Cornish J, Grey A. Skeletal actions of fasting-induced adipose factor (FIAF). Endocrinol. 2013;154:4685\u201394.","journal-title":"Endocrinol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4468-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4468-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4468-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T18:30:22Z","timestamp":1604255422000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4468-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4468"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4468-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"24 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Samples were collected with informed written donor consent in full compliance with national and institutional ethical requirements, the United Kingdom Human Tissue Act and the Declaration of Helsinki. This study was approved by the Oxford Clinical Research Ethics Committee (C01.071). No ethical approval was required for use of the osteosarcoma cell lines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"536"}}